A new coronavirus outbreak, which originated in the Chinese city of Wuhan and has spread throughout Asia and globally, has prompted people around the world to buy medical face masks in hopes of preventing infection.

Cervical cancer is the most common cause of cancer-related deaths in women in 42 low-income and lower-middle-income countries (LMICs), with the highest age-standardised incidence rates (40 cases per 100 000 women-years) occurring in 15 countries in sub-Saharan Africa. The gross disparity of the burden of this highly preventable disease, whereby 290 000 (51%) of the 570 000 new cases estimated to occur annually befall women in LMICs, has led many people to call attention to the need for urgent action.

As the number of people who have contracted coronavirus increases, several groups at universities in the US and Europe have rolled out predictions over the last few days about where and how the disease, which epidemiologists have now dubbed nCoV19, will spread next. 

Over half of the 37 million people worldwide living with HIV are receiving antiretroviral therapy (ART), yet only half of those people have suppressed replication of HIV with appropriate ART. A new project led by Dr. Paul Drain, an Associate Professor in the Departments of Global Health and Medicine at the University of Washington, aims to provide insight into the acceptability, feasibility, and impact of scaling-up the delivery of ART among adolescents and young adults living with HIV in community-based settings. Dr.